Chemed Corporation (NYSE:CHE) is among the 11 Best Long Term Low Risk Stocks to Invest in. The company recently revised its 2025 earnings forecast after reporting a 9.8% year-on-year revenue growth in Q1. Analysts have adjusted their price targets on the stock following the guidance update.

Chemed Corporation (NYSE:CHE) operates VITAS Healthcare and Roto-Rooter, offering hospice and palliative care and plumbing services, respectively. With a diverse portfolio, the Ohio-based company serves residential and commercial markets across the U.S.

Chemed Corporation (NYSE:CHE) announced a lower full-year earnings guidance for 2025 due to expected lower earnings in Q2. Despite this, the stock maintains a Buy rating from Bank of America and an Outperform rating from RBC Capital, with adjusted price targets.

Trading at $453.65, Chemed Corporation (NYSE:CHE) exhibits low volatility with a beta of 0.47 and moderate long-term growth potential with an EPS of 5.86% for the next 5 years. Investors seeking opportunities may find value in AI stocks with greater upside potential.

Read more at Yahoo Finance: Chemed updates 2025 forecast as Q1 revenue shows continued growth